Drugs that influence noradrenergic neurotransmission have made an enormous contribution to pharmacotherapy in psychiatry. David Heal, one of our Directors, and Clare Stanford, Department of Neuroscience, Physiology and Pharmacology, University College London, have recently written a chapter in the Handbook of Experimental Pharmacology describing how direct or indirect modulation of the function of specific adrenoceptor subtypes contributes to the efficacy and safety of drugs for the treatment of various psychiatric disorders including schizophrenia, depression, anxiety, attention-deficit hyperactivity disorder, binge-eating disorder and substance use disorder. This article is now available online.
Stanford, S.C., Heal, D.J. (2023). Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments. In: Handbook of Experimental Pharmacology. Springer, Berlin, Heidelberg.
Please click here for further information or contact us if this topic is of particular interest to you.